Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic GastritisAndrew R. Moore, D. Mark Pritchard, Fiona Campbell et al.|PLoS ONE|2013Cited by 64
Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumoursSenthil V. Murugesan, D. Mark Pritchard, Islay Steele et al.|European Journal of Gastroenterology & Hepatology|2012Cited by 13